Wajeeha Razaq to Breast Neoplasms
This is a "connection" page, showing publications Wajeeha Razaq has written about Breast Neoplasms.
Connection Strength
1.147
-
Evaluating the Response of Palbociclib on Progression-Free Survival in Hormone Receptor-Positive Metastatic Breast Cancer. Oncology. 2022; 100(6):337-343.
Score: 0.531
-
NRG-CC004 ancillary data study-exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms. J Sex Med. 2024 08 01; 21(8):709-715.
Score: 0.156
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early?breast cancer. Ann Oncol. 2022 Dec; 33(12):1250-1268.
Score: 0.138
-
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108). J Clin Oncol. 2022 03 20; 40(9):978-987.
Score: 0.131
-
Accelerated vascular aging and persistent cognitive impairment in older female breast cancer survivors. Geroscience. 2018 06; 40(3):325-336.
Score: 0.102
-
The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. 2016 05 24; 16:331.
Score: 0.089